Etzer Darout
Stock Analyst at Barclays
(4.95)
# 131
Out of 4,581 analysts
486
Total ratings
59.8%
Success rate
28%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Etzer Darout
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XNCR Xencor | Maintained: Buy | $27 | $19.53 | +38.25% | 31 | Jul 30, 2026 | |
| INCY Incyte | Reiterated: Buy | $134 → $139 | $127.10 | +9.36% | 17 | Jul 28, 2026 | |
| KURA Kura Oncology | Maintained: Buy | $28 | $8.93 | +213.55% | 13 | Jul 28, 2026 | |
| FBRX Forte Biosciences | Downgraded: Hold | $74 → $77 | $76.53 | +0.61% | 2 | Jul 27, 2026 | |
| SMMT Summit Therapeutics | Maintained: Hold | $18 | $12.80 | +40.63% | 10 | Jul 24, 2026 | |
| ANAB AnaptysBio | Maintained: Buy | $75 | $52.14 | +43.84% | 11 | Jul 23, 2026 | |
| MNPR Monopar Therapeutics | Maintained: Buy | $125 | $107.43 | +16.36% | 8 | Jul 23, 2026 | |
| TRAX First Tracks Biotherapeutics | Reiterated: Buy | $40 → $48 | $41.87 | +14.64% | 4 | Jul 21, 2026 | |
| IOVA Iovance Biotherapeutics | Rated: Buy | $11 | $4.56 | +141.23% | 11 | Jul 20, 2026 | |
| SNDX Syndax Pharmaceuticals | Rated: Buy | $37 | $19.22 | +92.51% | 14 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $45 → $49 | $55.33 | -11.44% | 33 | Jul 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $253 → $260 | $255.97 | +1.57% | 6 | Jul 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $409 → $403 | $327.21 | +23.16% | 8 | Jul 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $119 → $151 | $133.00 | +13.53% | 10 | Jul 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 | $18.85 | +324.40% | 10 | Jul 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $3 | $2.14 | +40.19% | 6 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $148 | $118.84 | +24.54% | 11 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $3.52 | +98.86% | 29 | Jun 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $55 | $49.06 | +12.11% | 19 | Jun 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $8.22 | +143.31% | 35 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $8.64 | +247.22% | 10 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 → $27 | $18.37 | +46.98% | 6 | May 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $13.04 | +114.72% | 6 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $160 | $88.07 | +81.67% | 7 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $6 | $3.67 | +63.49% | 33 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $45 → $48 | $37.51 | +27.97% | 7 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $16 | $3.17 | +404.73% | 30 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $14 | $14.96 | -6.42% | 6 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $70 → $119 | $105.25 | +13.06% | 5 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $4.51 | n/a | 1 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $130 → $143 | $92.95 | n/a | 10 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $158.83 | n/a | 7 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.36 | n/a | 16 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $14.64 | n/a | 4 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $28.52 | n/a | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $23.60 | n/a | 2 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.74 | n/a | 7 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.43 | n/a | 10 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $63 | $0.6001 | n/a | 3 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | kr 2,445 → kr 2,612 | kr 1,892 | n/a | 2 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 → $37 | $107.57 | n/a | 2 | Sep 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $60 | $0.4817 | n/a | 1 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7 | $0.00001 | n/a | 1 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $25 | $6.32 | n/a | 2 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $48 | $3.81 | n/a | 2 | Mar 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €22.70 → €26.19 | €3.83 | n/a | 2 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $162 | $286.62 | n/a | 1 | Feb 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $48 | $22.01 | n/a | 4 | Jul 14, 2020 |
Xencor
Jul 30, 2026
Maintained: Buy
Price Target: $27
Current: $19.53
Upside: +38.25%
Incyte
Jul 28, 2026
Reiterated: Buy
Price Target: $134 → $139
Current: $127.10
Upside: +9.36%
Kura Oncology
Jul 28, 2026
Maintained: Buy
Price Target: $28
Current: $8.93
Upside: +213.55%
Forte Biosciences
Jul 27, 2026
Downgraded: Hold
Price Target: $74 → $77
Current: $76.53
Upside: +0.61%
Summit Therapeutics
Jul 24, 2026
Maintained: Hold
Price Target: $18
Current: $12.80
Upside: +40.63%
AnaptysBio
Jul 23, 2026
Maintained: Buy
Price Target: $75
Current: $52.14
Upside: +43.84%
Monopar Therapeutics
Jul 23, 2026
Maintained: Buy
Price Target: $125
Current: $107.43
Upside: +16.36%
First Tracks Biotherapeutics
Jul 21, 2026
Reiterated: Buy
Price Target: $40 → $48
Current: $41.87
Upside: +14.64%
Iovance Biotherapeutics
Jul 20, 2026
Rated: Buy
Price Target: $11
Current: $4.56
Upside: +141.23%
Syndax Pharmaceuticals
Jul 20, 2026
Rated: Buy
Price Target: $37
Current: $19.22
Upside: +92.51%
Jul 14, 2026
Maintained: Hold
Price Target: $45 → $49
Current: $55.33
Upside: -11.44%
Jul 14, 2026
Maintained: Buy
Price Target: $253 → $260
Current: $255.97
Upside: +1.57%
Jul 14, 2026
Maintained: Buy
Price Target: $409 → $403
Current: $327.21
Upside: +23.16%
Jul 14, 2026
Maintained: Buy
Price Target: $119 → $151
Current: $133.00
Upside: +13.53%
Jul 14, 2026
Maintained: Buy
Price Target: $80
Current: $18.85
Upside: +324.40%
Jul 8, 2026
Maintained: Sell
Price Target: $3
Current: $2.14
Upside: +40.19%
Jun 30, 2026
Maintained: Buy
Price Target: $148
Current: $118.84
Upside: +24.54%
Jun 22, 2026
Maintained: Buy
Price Target: $7
Current: $3.52
Upside: +98.86%
Jun 18, 2026
Maintained: Buy
Price Target: $55
Current: $49.06
Upside: +12.11%
Jun 3, 2026
Maintained: Buy
Price Target: $20
Current: $8.22
Upside: +143.31%
Jun 1, 2026
Maintained: Buy
Price Target: $30
Current: $8.64
Upside: +247.22%
May 20, 2026
Maintained: Buy
Price Target: $21 → $27
Current: $18.37
Upside: +46.98%
May 15, 2026
Maintained: Buy
Price Target: $28
Current: $13.04
Upside: +114.72%
May 13, 2026
Rated: Buy
Price Target: $160
Current: $88.07
Upside: +81.67%
May 13, 2026
Rated: Buy
Price Target: $6
Current: $3.67
Upside: +63.49%
May 8, 2026
Rated: Buy
Price Target: $45 → $48
Current: $37.51
Upside: +27.97%
May 8, 2026
Rated: Buy
Price Target: $16
Current: $3.17
Upside: +404.73%
May 8, 2026
Rated: Sell
Price Target: $14
Current: $14.96
Upside: -6.42%
Dec 8, 2025
Maintained: Buy
Price Target: $70 → $119
Current: $105.25
Upside: +13.06%
Apr 4, 2025
Maintained: Buy
Price Target: $9
Current: $4.51
Upside: n/a
Mar 11, 2025
Maintained: Buy
Price Target: $130 → $143
Current: $92.95
Upside: n/a
Mar 4, 2025
Rated: Hold
Price Target: n/a
Current: $158.83
Upside: n/a
Mar 4, 2025
Rated: Hold
Price Target: n/a
Current: $2.36
Upside: n/a
Mar 4, 2025
Rated: Hold
Price Target: n/a
Current: $14.64
Upside: n/a
Mar 4, 2025
Rated: Hold
Price Target: n/a
Current: $28.52
Upside: n/a
Mar 4, 2025
Rated: Hold
Price Target: n/a
Current: $23.60
Upside: n/a
Mar 4, 2025
Rated: Hold
Price Target: n/a
Current: $4.74
Upside: n/a
Mar 4, 2025
Rated: Hold
Price Target: n/a
Current: $1.43
Upside: n/a
Feb 27, 2025
Initiated Coverage: Buy
Price Target: $63
Current: $0.6001
Upside: n/a
Aug 11, 2022
Maintained: Hold
Price Target: kr 2,445 → kr 2,612
Current: kr 1,892
Upside: n/a
Sep 13, 2021
Maintained: Buy
Price Target: $38 → $37
Current: $107.57
Upside: n/a
May 18, 2021
Initiated Coverage: Buy
Price Target: $60
Current: $0.4817
Upside: n/a
May 18, 2021
Initiated Coverage: Buy
Price Target: $7
Current: $0.00001
Upside: n/a
Mar 17, 2021
Maintained: Buy
Price Target: $16 → $25
Current: $6.32
Upside: n/a
Mar 11, 2021
Reiterated: Buy
Price Target: $50 → $48
Current: $3.81
Upside: n/a
Mar 5, 2021
Maintained: Buy
Price Target: €22.70 → €26.19
Current: €3.83
Upside: n/a
Feb 22, 2021
Downgraded: Hold
Price Target: $162
Current: $286.62
Upside: n/a
Jul 14, 2020
Maintained: Buy
Price Target: $48
Current: $22.01
Upside: n/a